Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Long-Term Investments (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Long-Term Investments data on record, last reported at $45.4 million in Q3 2025.

  • On a quarterly basis, Long-Term Investments fell 37.46% to $45.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $45.4 million, a 37.46% decrease, with the full-year FY2024 number at $113850.0, down 99.84% from a year prior.
  • Long-Term Investments reached $45.4 million in Q3 2025 per AFJK's latest filing, up from $44.5 million in the prior quarter.
  • Over the last five years, Long-Term Investments for AFJK hit a ceiling of $72.7 million in Q3 2024 and a floor of $113850.0 in Q4 2024.
  • A 3-year average of $52.3 million and a median of $57.7 million in 2023 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: crashed 99.84% in 2024, then tumbled 37.46% in 2025.
  • Tracing AFJK's Long-Term Investments over 3 years: stood at $69.9 million in 2023, then plummeted by 99.84% to $113850.0 in 2024, then skyrocketed by 39815.3% to $45.4 million in 2025.
  • Business Quant data shows Long-Term Investments for AFJK at $45.4 million in Q3 2025, $44.5 million in Q2 2025, and $43.6 million in Q1 2025.